MJ - ETFMG Alternative Harvest ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
33.88
-0.21 (-0.62%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close34.09
Open34.93
Bid33.88 x 3200
Ask34.53 x 800
Day's Range33.75 - 34.94
52 Week Range23.01 - 45.40
Volume795,397
Avg. Volume952,319
Net Assets1.23B
NAV33.84
PE Ratio (TTM)N/A
Yield1.74%
YTD Return36.53%
Beta (3Y Monthly)2.40
Expense Ratio (net)0.75%
Inception Date2015-12-03
Trade prices are not sourced from all markets
  • Benzinga13 hours ago

    4/20 In 2019: What Cannabis Businesses Should Expect

    Thanksgiving has already become one of the best-selling periods for cannabis businesses, with the day before Thanksgiving becoming known as Green Wednesday. Traditionally, April 20 remains the biggest and most exciting holiday for cannabis consumers and is known as 4/20. Business analytics software provider Headset took into account data from states where cannabis has had the longest presence —  Washington, California, Nevada and Colorado — and compared trends over the last four years.

  • How Risky are Cannabis Investors?
    Investopediayesterday

    How Risky are Cannabis Investors?

    While cannabis stocks are blazing with popularity, our survey of readers shows that they are still not willing to commit their portfolios to the risky sector

  • Benzingayesterday

    Former Detroit Lions Calvin Johnson, Rob Sims Discuss Cannabis, Ending The Stigma And The NFL's Stance

    Former Detroit Lions players Calvin Johnson and Rob Sims joined Benzinga CEO Jason Raznick onstage Wednesday at the Cannabis Capital Conference in Toronto. Johnson and Sims discussed industry activity in Michigan, their experiences in the NFL and ending the stigma around cannabis in specific communities. For Sims, cannabis has a personal connection.

  • Likely Canopy-Acreage Deal Looks Good Enough to Boost ETF MJ
    Zacksyesterday

    Likely Canopy-Acreage Deal Looks Good Enough to Boost ETF MJ

    Canopy Growth will probably purchase the rights to buy Acreage Holdings to tap the growing potential of the U.S. marijuana market. This should bolster the ETF MJ.

  • Canopy Growth to Acquire Acreage Holdings
    Market Realistyesterday

    Canopy Growth to Acquire Acreage Holdings

    Canopy Growth to Acquire Acreage HoldingsCanopy Growth to Acquire Acreage Holdings On April 18, Canopy Growth (WEED) (CGC) announced that it entered an agreement to acquire Acreage Holdings. Acreage Holdings has a presence in 20 states in the US

  • ETF.comyesterday

    New Marijuana ETF Goes Live

    The AdvisorShares Pure Cannabis ETF is the second—and cheapest—marijuana ETF on the market.

  • What’s the Consensus Analyst View on Canopy Growth in April?
    Market Realist2 days ago

    What’s the Consensus Analyst View on Canopy Growth in April?

    Canopy Growth Trades Higher on Talks with Acreage Holdings(Continued from Prior Part)Consensus viewOn April 17, Bank of America Merrill Lynch initiated coverage on Canopy Growth (WEED) (CGC) with a “buy” rating. The stock has a price target

  • MarketWatch2 days ago

    Canopy confirms $3.4 billion deal to buy Acreage, once cannabis becomes legal in the U.S.

    Canada-based Canopy Growth Corp. confirmed Thursday a deal for the right to buy New York-based Acreage Holdings Inc. in a deal that valued at $3.4 billion, when the production and sale cannabis becomes federally legal in the U.S. Canopy's stock soared 8.7% in premarket trade. MarketWatch had reported Wednesday, citing a source familiar with the negotiations, that the deal for the rights to buy Acreage was "98% done." Canopy said the purchase price represents a 41.7% premium over the 30-day volume-weighted average price of Acreage's subordinate voting shares. The deal includes a $150 million termination fee, payable by Acreage. "Today we announce a complex transaction with a simple objective," said Canopy Chief Executive Bruce Linton. "Our right to acquire Acreage secures our entrance strategy into the United States as soon as a federally-permissible pathway exists." Canopy's stock has run up 59.5% year to date through Wednesday and Acreage's stock has climbed 17.5%, while the ETFMG Alternative Harvest ETF has rallied 36.7% and the S&P 500 has gained 15.7%.

  • Benzinga2 days ago

    SLANG, Compass Cannabis Execs Talk Industry Development: 'Capital Flows To ... Where It's Most Rewarded'

    In one of several fireside chats taking place at the Benzinga Cannabis Capital Conference, Dave Martyn, president of the Compass Cannabis chain of Canadian dispensaries, sat down Wednesday with Peter Miller, CEO of cannabis branding and packaging company SLANG Worldwide. The two discussed the intersection of Canada's newly legalized industry with the burgeoning U.S. market. Early in the conversation, they landed on the topic of just how far the cannabis industry has come in the years leading up to broad legalization in both Canada and the U.S. — and why that exponential growth foreshadows even greater developments in the coming years.

  • Canopy Growth isn’t buying Acreage Holdings, it’s buying the right to buy Acreage Holdings
    MarketWatch2 days ago

    Canopy Growth isn’t buying Acreage Holdings, it’s buying the right to buy Acreage Holdings

    Canopy Growth Corp. is not outright acquiring Acreage Holdings Inc., as reports said Wednesday, but it is preparing to pay billions for the rights to buy the U.S.-based pot company.

  • This is the only place to get Carl’s Jr.’s CBD-infused cheeseburger on 4/20
    MarketWatch2 days ago

    This is the only place to get Carl’s Jr.’s CBD-infused cheeseburger on 4/20

    Burger chain Carl’s Jr. will test a CBD-infused cheeseburger for one day, 4/20 of course, at one restaurant in Denver, and in time for breakfast.

  • Investopedia2 days ago

    How First U.S. ETF With 'Cannabis' in Name Plans to Beat Skeptics

    The AdvisorShares Pure Cannabis ETF, or YOLO, plans to undercut its competitors with pricing and debut just days before an unofficial pot holiday.

  • Benzinga2 days ago

    Legal Marijuana's Pivot From Canada To US, Beyond Is Accelerating

    After the global industry jolt in 2018 when Canada legalized the recreational and medical use of cannabis, licensed producers and investors are well into a pivot to the U.S. market and beyond for future growth. Canadian cannabis players failed last year to use their first-to-market profile and strong currency to dominate a U.S. market 10 times bigger than their own, said Alfred Avanessy, managing director of Cormark Securities. For investors, as fragmented U.S. state policies are possibly replaced with federally legalized cannabis use down the road, the market valuations put on American companies are expected to continue to climb.

  • Checking Up on TLRY, IIPR, APHA, and Other Cannabis Stocks
    Market Realist2 days ago

    Checking Up on TLRY, IIPR, APHA, and Other Cannabis Stocks

    CGC, HEXO, CTST Moving Higher Today(Continued from Prior Part)Tilray mutedOn April 17, Tilray (TLRY) remained muted, with the stock almost flat as of noon. The stock remained depressed as the overall cannabis industry has slumped in April.

  • CGC, HEXO, CTST Moving Higher Today
    Market Realist2 days ago

    CGC, HEXO, CTST Moving Higher Today

    CGC, HEXO, CTST Moving Higher TodayCannabis sector gains Today, the Horizons Marijuana Life Sciences ETF (HMMJ) gained about 0.3% and the ETFMG Alternative Harvest ETF (MJ) gained about 0.3% in the first half of the trading session. However, the

  • ETF Trends2 days ago

    Legalization Survey Lifts Marijuana ETF

    The ETFMG Alternative Harvest ETF (MJ) , the only dedicated cannabis exchange traded fund (ETF) listed in the U.S., traded higher Tuesday following the release of a survey that indicates an increasing number of people favor legalization of marijuana. MJ seeks to provide investment results that correspond generally to the total return performance of the Prime Alternative Harvest Index. “The General Social Survey conducted by NORC at the University of Chicago found 61% of those surveyed supported legalization, up from 57% in 2016 and 31% in 2000,” reports Ciarra Linnane for MarketWatch.

  • ACB, CRON, and CGC Get Ratings Coverage from BofA Merrill Lynch
    Market Realist2 days ago

    ACB, CRON, and CGC Get Ratings Coverage from BofA Merrill Lynch

    BofA Merrill Lynch Initiated Coverage on Canopy Growth(Continued from Prior Part)Analysts’ ratings Early on April 17, Bank of America Merrill Lynch initiated coverage on three cannabis stocks. Aurora Cannabis (ACB) received a “buy”

  • Benzinga2 days ago

    YOLO? US Investors Are Getting Another Cannabis ETF

    U.S. investors craving cannabis exposure via the exchange traded funds have, since late 2017, one choice: the ETFMG Alternative Harvest ETF (NYSE: MJ). AdvisorShares' efforts to launch YOLO were highlighted in a Securities and Exchange Commission filing out earlier this year.

  • Analysts Remain Unfazed about Aphria’s Ratings after Earnings
    Market Realist3 days ago

    Analysts Remain Unfazed about Aphria’s Ratings after Earnings

    Irwin Simon Says Aphria Will Hit 1 Billion in Sales by 2020(Continued from Prior Part)Analyst ratings The consensus analyst rating on Aphria (APHA) after its earnings were released remained unchanged compared to the previous month. As the chart

  • 2 Hot Marijuana Stocks to Watch This Week
    InvestorPlace3 days ago

    2 Hot Marijuana Stocks to Watch This Week

    Faith in marijuana stocks is starting to dissipate at the start of the week after a number of headwinds from last week have continued to leach into investors' minds and force them to question the longer-term strength of the marijuana space more broadly. The two pot stocks we're watching this week are Aphria (NYSE:APHA) and Tilray (NASDAQ:TLRY).Source: Shutterstock Last week, one of Cowen & Co.'s top marijuana market analysts, Vivien Azer, cited potential headwinds that could bear down on cannabis producers.And yesterday morning, a major earnings disaster in a popular pot stock echoed the analysts' concerns as well as a preexisting narrative that sales of marijuana might slow considerably in the months ahead.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSpecifically, Azer cited oversupply and quality control issues as reasons for "lowering her first-half expectations for a handful of Canadian growers." In some cases, the lower quality cannabis might be "un-sellable." The ETFMG Alternative Harvest ETF (NYSEARCA:MJ), which tracks key marijuana growers, dropped more than 5% over the past five days as a result of the negative outlook.And Aphria -- yesterday morning's big-time earnings flop -- dropped nearly 15% on Monday, April 15.After considering this lackluster product and the possibility of fewer sales, the short-term case for some marijuana stocks has certainly become a bit murkier. But is it all doom and gloom in the marijuana space?The following are two of the key cannabis stocks to watch this week: Aphria and Tilray. Aphria (APHA)The pain APHA investors suffered Monday morning will remain seared in the minds of marijuana stock investors for days to come. Aphria reported "[a]n adjusted net loss of C$0.20 per share … year-over-year, and missed the Street by C$0.16." * 10 Stocks That Are Screaming Buys Right Now But perhaps more damaging for the stock wasn't its failure to satisfy Wall Street estimates, as InvestorPlace contributor Vince Martin points out in his earnings breakdown, only a few analysts are currently setting the tone for APHA stock.Rather, upon closer examination, it's the less impressive growth narrative for the stock that has caused some investors to flee. In Martin's words, although "[r]evenue rose 617% year-over-year … the numbers aren't as impressive as the headlines suggest. Aphria is growing its pot business -- but perhaps not as fast as a $2 billion-plus valuation suggests it should be."Adding to the sizable dip in APHA stock is the fact that a potential buyout by Green Growth Brands (OTCMKTS:GGBXF) is no longer on the books, causing some investors to question whether the company can hold its own against the competition or if the company might not see another offer any time soon. Tilray (TLRY)TLRY stock joined Aphria in the dive yesterday, dropping more than 7%.In-line with Azer's assessment of the marijuana space last week, TLRY stock has come under scrutiny lately for potential oversupply issues in Canada, which might affect the company's longer-term growth narrative. The hype around the pot business is expected to lose some of its vigor as supply and demand for marijuana begin to balance out. * 7 Dental Stocks to Buy That Will Make You Smile Adding salt to the wound in Tilray is the fact that the negative outlook isn't just coming from analysts, nor is it just confirmed by its peers in the space like APHA. As InvestorPlace Feature Writer James Brumley asserts in his latest in-depth analysis of TLRY stock, the less-than-positive perspective came straight from Tilray's CEO Brendan Kennedy during a March earnings call, where he stated that he expects marijuana to "erode in value in the medium to long term, as the market normalizes." This normalization is expected to occur "[o]ver the next 18 months."Despite the negative short-term outcast, analysts still collectively expect an upside of more than 87% for TLRY stock over the next 12 months (an average price target of $107). Whether this is a realistic number for TLRY to reach may become clearer when the company next reports earnings on Jun. 17.Wall Street still expects an earnings-per-share loss of 29 cents on revenues of $24.85 million for the report. But we might expect the story behind Tilray (and analysts expectations) to change in light of Aphira's earnings-based pain yesterday.As of this writing, Robert Waldo did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Medical Marijuana Stocks to Cure Your Portfolio * 8 Best Stocks to Buy for an April Rally * Top 20 Stocks to Buy for 20-Somethings! Compare Brokers The post 2 Hot Marijuana Stocks to Watch This Week appeared first on InvestorPlace.

  • Aphria Trading Higher After the Big Selloff Yesterday
    Market Realist3 days ago

    Aphria Trading Higher After the Big Selloff Yesterday

    TLRY, CGC, ACB Snap Out of Their Losing Streaks(Continued from Prior Part)Aphria trading higher Aphria (APHA) lost about 14% in yesterday’s trading session after it reported its earnings. The company wrote off 50 million Canadian dollars relating

  • Marijuana ETF Down 9% in Past Month: Time to Enter the Space?
    Zacks3 days ago

    Marijuana ETF Down 9% in Past Month: Time to Enter the Space?

    Growing global acceptance, increasing legalization and beaten-down prices open up room for marijuana ETF investing.

  • Canopy Growth Continues to Expand amid Market Weakness
    Market Realist3 days ago

    Canopy Growth Continues to Expand amid Market Weakness

    Canopy Growth Continues to Expand amid Market WeaknessMarket weaknessThe cannabis sector has weakened recently. Most cannabis stocks ended March in negative territory, and this trend has worsened in April. Tilray (TLRY) and CannTrust (CTST) have

  • Benzinga3 days ago

    Canadian Investors Can Light Up A New Cannabis ETF Focused On US Companies

    Horizons is the company behind the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ)(OTC: HMLSF), which is one of the world's largest cannabis ETFs. “HMUS will be the first ETF in the world that is solely focused on providing exposure to companies with significant business activities in, or significant exposure to, the United States marijuana or hemp industries,” according to a statement.

  • ETF Trends3 days ago

    3 IPOs Debuting This Week, ETFs to Catch the IPO Action

    Ridesharing companies Lyft and Uber have been igniting interest the past couple of weeks in the initial public offering space (IPO) with the former debuting earlier this month and the latter set to launch mid-May. Amid a week of more first-quarter corporate earnings reports, three other IPOs are set to debut and get their taste of the public limelight. 1. Digital scrapbooking site Pinterest is set to debut its initial public offering (IPO) at an initial price of $15 to $17 a share, according to its latest prospectus, which will peg the value of the company at roughly $11 billion. The Pinterest IPO follows the ridesharing company Lyft, which made its debut at $72 a share before falling in the following days after initial trading. 2.